TrialBreast cancer research : BCR2011

The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.

Stephen B Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.